Verve Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Verve Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Verve Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $104K, a 55.2% increase year-over-year.
  • Verve Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $308K.
  • Verve Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $275K, a 419% increase from 2022.
  • Verve Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $53K.
  • Verve Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.